360 MASSACHUSETTS AVENUE, SUITE 203, ACTON, MA
Market cap: $1.2M (2/12/2026)
Price: $2.67
Announces 1-for-4 Reverse Stock Split
Announces Completion of Commercial-Scale IL-6 Antibody Production
Corporate Update: Advancing Clinical Milestones and Strategic Partnerships
Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Expand Strategic Partnership to Advance Commercialization of Symphony Platform
Other Events
Provides Second Quarter Business and Corporate Update
News, Material Contracts
Q3
Q2
Q1
Amended Annual Report
FY 2024
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Amended Registration Statement for Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Prospectus Filed Pursuant to Rule 424(b)(1)
Correspondence
Submission Upload